Delinquent-filing notices pile up at the small end of Nasdaq, on a clock that runs differently from the bid-price rule
Premium Catering (Holdings) Limited (Nasdaq: PC) disclosed on Wednesday that Nasdaq sent it a delinquency letter dated Sept. 4 under Listing Rule 5250(c)(1). At issue is the Singapore-based caterer's Form 6-K interim report — the interim balance sheet and income statement for the fiscal half year ended Dec. 31, 2025 — which had not been filed. The company said it has 60 calendar days from the date of the delinquency letter "to submit a plan to regain compliance," and that if Nasdaq accepts the plan the staff may grant an exception of up to "180 calendar days from the date of the 2026 Interim Report's due date, or December 28, 2026." Its release does not state why the report is late.
Premium Catering is the fourth issuer in roughly three weeks to make such a disclosure, and the pattern is worth reading closely, because the filing rule's clock works differently from the bid-price clock that has dominated small-cap listing coverage this year.
Rule 5250(c)(1) is the periodic-reporting standard. Anavex Life Sciences, announcing its own return to compliance on Sept. 2, described the rule as one that "requires Nasdaq-listed companies to file all required periodic filings with the Securities and Exchange Commission." A missed 10-Q, 10-K or, for foreign private issuers, an interim report on Form 6-K, puts an issuer out of compliance on the filing's due date.
The remedy runs in two stages, both expressed in calendar days. First, the issuer has 60 calendar days from the notice to submit a compliance plan. Second, if the staff accepts that plan, it may grant an exception of up to 180 calendar days measured from the delinquent report's due date. That second measurement matters: because the outer limit is anchored to the due date rather than to the notice, an issuer that is already months late has correspondingly less runway left inside the 180-day window than one that missed by days.
Netcapital Inc. (Nasdaq: NCPL) illustrates the mechanics. In an Aug. 28 release the company said Nasdaq notified it on Aug. 24 that it had not filed its Form 10-K for the fiscal year ended April 30, 2026. Netcapital said it has "60 calendar days from receipt of the Notice, or until October 23, 2026" to submit a plan, and that if the plan is accepted Nasdaq may allow up to "180 calendar days from the Form 10-K's due date, or until February 9, 2027." The release gives no reason for the delay.
SolarMax Technology, Inc. (Nasdaq: SMXT) disclosed on Aug. 21 that it received a letter dated Aug. 20 covering its Form 10-Q for the quarter ended June 30, 2026. The company said it has "60 calendar days from August 20, 2026, which is October 19, 2026, to submit a plan to regain compliance," and that "if Nasdaq accepts the Company's plan, Nasdaq can grant an exception of up to 180 days from the filing's due date, which would be February 16, 2027." That release likewise does not explain the delay.
SolarMax is also the clearest case of an issuer running several deficiency tracks at once, and of why the clocks must not be conflated. In a separate Aug. 11 release, the company said it had received a Nasdaq bid-price notice dated March 3, 2026, that the resulting compliance period was "180 calendar days" and expired Aug. 31, 2026, and that it would carry out a 1-for-12 reverse stock split effective Aug. 13 at 12:01 a.m. Eastern time. The same Aug. 11 release disclosed a further, separate deficiency: a notice dated June 22, 2026 concerning Nasdaq's $35 million minimum market value of listed securities requirement, carrying its own 180-calendar-day compliance period expiring Dec. 21, 2026. Three notices, three bases, three dates.
The cure standard in that same release is the point non-specialists most often get wrong. SolarMax stated that to regain compliance "the closing bid price of the Company's common stock must be at least $1 per share for a minimum of ten consecutive business days." So the bid-price compliance period is counted in calendar days — 180 of them — while the cure itself is counted in business days, ten consecutive sessions at or above a dollar. Those are different units, and converting one into the other produces a wrong date. The filing rule, by contrast, is expressed in calendar days at both stages.
Only one of the four delinquent filers gave a substantive reason. Borealis Foods Inc. (Nasdaq: BRLS) said on Sept. 2 that it had received a letter dated Aug. 26 regarding its Form 10-Q for the quarter ended June 30, 2026, and that it "has until October 26, 2026 to submit a plan of compliance to Nasdaq." The company said it "was otherwise prepared to file the Q2-2026 Form 10-Q on a timely basis; however, the filing was delayed by the need to complete a review, together with its independent auditors, of the appropriate accounting treatment of the Company's previously disclosed Conversion Agreement," and that it "intends to file the Q2-2026 Form 10-Q promptly upon completion of that review." It did not give a target date.
A disclosed accounting review is a different kind of disclosure from silence. It identifies a specific, bounded question — how one previously disclosed agreement should be accounted for — and names the auditors as participants. It does not, on its own, indicate the outcome of that review, and Borealis did not characterise the review's likely effect on reported results.
The cure side of the ledger shows the process can close quickly. Anavex Life Sciences Corp. (Nasdaq: AVXL) said it filed its Form 10-Q reports for the second and third fiscal quarters of 2026 on Aug. 28, and announced on Sept. 2 that it had received confirmation from Nasdaq that it had regained compliance with Rule 5250(c)(1). The release does not date the confirmation letter itself. No plan-of-compliance process was described; the filings themselves resolved the deficiency.
What none of these letters is, is a delisting decision. Each is a staff notice that starts a process, and each of the four companies retains the ability to file the missing report — which, as Anavex's case shows, is the shortest route out. What the notices do change is the disclosure record: an issuer under a 5250(c)(1) letter has told the market that its most recent audited or reviewed financial statements are not available on schedule, which is a material fact for anyone pricing the security.
For the smallest issuers, the compounding risk is the one SolarMax's multi-track situation demonstrates. A company can be inside a bid-price compliance period and a filing-plan window simultaneously, with separate deadlines on separate bases, and satisfying one does nothing for the other. Nasdaq's acceptance of a compliance plan is discretionary; none of the four releases reported that a plan had been submitted or accepted, and each set out a submission deadline still in the future.
The near-term dates to watch are the plan-submission deadlines the companies themselves have published: Oct. 19 for SolarMax, Oct. 23 for Netcapital, Oct. 26 for Borealis Foods, and 60 calendar days from Sept. 4 for Premium Catering. Whether any of them files the underlying report first — the outcome that ends the matter outright — is the more consequential question, and none of the four has committed to a date.
